This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of teriflunomide
MSMED_TERIFLUNOMIDE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
395 |
4. Check minimum number of events
Min. number of events
3
|
395 |
5. Include endpointsNone |
395 |
6. Filter based on genotype QC (FinnGen only) |
395 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Use of teriflunomide
based on the number of shared cases.
Similar with more cases:
- MS-disease / Multiple Sclerosis
- Demyelinating diseases of the central nervous system
- L04AA Selective immunosuppressants
- Other degenerative diseases of the nervous system
- ILD medications: immunosuppressive drugs
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 395 | 294 | 101 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.04 |
| Median age at first event (years) | 44.65 | 45.13 | 43.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 349
- Matched controls
- 3488
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
3651.1
323.0
334
20
L04AA31
ATC
teriflunomide; oral
+∞
323.0
349
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
323.0
349
28
109
Kela drug reimbursment
Multiple sclerosis
8598.0
323.0
344
24
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
323.0
349
19
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
53.2
183.8
228
119
L03AB07
ATC
interferon beta-1a; parenteral
322.9
178.9
168
10
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
165.7
139.8
140
14
L03AX13
ATC
glatiramer acetate; parenteral
175.8
124.9
125
11
H46
ICD-10 Finland
Optic neuritis
98.8
106.5
114
17
N86
ICPC
Multiple sclerosis
166.1
103.8
105
9
TAB00
NOMESCO Finland
Lumbar puncture
28.1
100.3
142
83
L03AB08
ATC
interferon beta-1b; parenteral
177.8
81.0
82
6
L04AX07
ATC
dimethyl fumarate; oral
187.0
73.2
74
5
C10AC01
ATC
colestyramine; oral
36.4
66.8
86
31
N07XX09
ATC
[U] dimethyl fumarate; oral
202.6
65.5
66
*
N04BB01
ATC
amantadine; oral
48.2
65.4
79
21
164
Kela drug reimbursment
Fingolimod
83.3
56.3
62
9
353
Kela drug reimbursment
Cladribine and fingolimod
77.7
47.7
53
8
XA800
NOMESCO Finland
Neuropsychological investigation
18.4
47.4
75
51
G04BD12
ATC
mirabegron; oral
13.0
46.0
85
84
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.7
41.3
90
121
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
31.7
40.9
54
20
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
25.9
40.8
57
26
L04AA27
ATC
fingolimod; oral
77.1
36.9
41
6
R20.2
ICD-10 Finland
Paraesthesia of skin
8.4
36.6
87
133
XKD00
NOMESCO Finland
Uroflowmetry
9.5
34.5
75
98
XKD06
NOMESCO Finland
Physiologic investigation of micturition
24.5
33.2
47
22
M03BX01
ATC
baclofen; systemic
23.3
31.4
45
22
2AB04
NOMESCO Finland
NA
121.1
31.2
33
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
22.3
31.0
45
23
G04BD09
ATC
trospium; oral
36.4
30.7
39
12
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
9.1
30.4
67
89
L03AB13
ATC
peginterferon beta-1a; parenteral
329.5
30.3
30
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.2
29.4
103
258
XCK00
NOMESCO Finland
Perimetry
9.6
29.2
62
77
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
292.4
27.1
27
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
7.1
21.9
56
92
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.1
21.0
40
40
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.4
20.9
67
147
H02AB04
ATC
methylprednisolone; systemic
4.0
19.8
90
280
ZX120
NOMESCO Finland
Intravenous
4.9
19.0
66
158
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
15.7
18.0
29
20
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
39.0
17.8
22
6
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
25.6
17.6
24
10
R35
ICD-10 Finland
Polyuria
8.1
17.6
40
55
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
17.4
16.8
26
16
UKC02
NOMESCO Finland
Cystoscopy
4.8
16.8
59
142
XKC03
NOMESCO Finland
Water cystometry
14.4
16.8
28
21
G04BD08
ATC
solifenacin; oral
7.4
16.6
40
60
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
35.2
15.9
20
6
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
10.4
15.0
29
30
N06BA07
ATC
modafinil; oral
19.5
14.9
22
12
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.9
14.8
42
79
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.6
14.7
53
131
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
37.8
14.6
18
5
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
9.7
14.0
28
31
R1250
NOMESCO Finland
Evaluation of functional capability
9.1
13.5
28
33
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
27.0
13.5
18
7
H53.2
ICD-10 Finland
Diplopia
10.3
13.5
26
27
G04BD07
ATC
tolterodine; oral
9.1
13.0
27
32
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.4
12.8
47
118
TKC22
NOMESCO Finland
Catheterisation instruction
13.9
12.6
21
16
R4110
NOMESCO Finland
Physiotherapy
2.6
12.1
107
512
N03AX12
ATC
gabapentin; oral
3.1
11.9
73
276
R4150
NOMESCO Finland
Neuropsychological rehabilitation
19.8
11.7
17
9
XCD10
NOMESCO Finland
Electrophysiological examination of eye
10.6
11.2
21
21
G04BD04
ATC
oxybutynin; oral, transdermal
6.7
10.9
27
43
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.7
10.7
36
83
A02BC02
ATC
pantoprazole; systemic
2.1
10.5
224
1591
N06AX16
ATC
venlafaxine; oral
2.7
10.3
80
349
R33
ICD-10 Finland
Retention of urine
6.6
10.1
25
40
L04AA40
ATC
cladribine; oral
56.6
9.7
11
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
9.4
9
*
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
+∞
9.4
9
*
N03AE01
ATC
clonazepam; systemic
4.2
8.9
33
84
H53.1
ICD-10 Finland
Subjective visual disturbances
3.7
8.7
37
107
N03AX16
ATC
pregabalin; oral
2.3
8.6
92
472
J01EA01
ATC
trimethoprim; systemic
2.2
8.6
100
537
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
92.2
8.4
9
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
34.2
8.1
10
*
R42
ICD-10 Finland
Dizziness and giddiness
2.5
8.0
69
318
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
6.2
7.8
20
34
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.4
7.7
22
43
N04BD01
ATC
selegiline; oral
18.9
7.6
11
6
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
12.2
7.6
13
11
SPAT1229
SPAT
Assessment of need for aid
4.3
7.6
27
67
R4120
NOMESCO Finland
Occupational therapy
3.5
7.5
34
104
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
81.8
7.4
8
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
11.2
7.4
13
12
SPAT1216
SPAT
Assessment of functional ability
3.0
7.3
41
146
N06
ICPC
Sensation disturbance other
16.2
7.3
11
7
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
16.2
7.3
11
7
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
30.7
7.2
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.1
293
2477
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
7.1
86
465
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
14.1
6.9
11
8
M03BX02
ATC
tizanidine; oral
1.9
6.8
248
1979
4AA23
NOMESCO Finland
NA
40.9
6.8
8
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
7.4
6.8
15
21
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
10.3
6.6
12
12
TKC20
NOMESCO Finland
Catheterisation of bladder
4.1
6.5
24
62
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.5
6.3
28
85
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
6.3
41
163
L01BB04
ATC
cladribine; systemic
+∞
6.3
6
*
G37.8
ICD-10 Finland
Other specified demyelinating diseases of central nervous system
+∞
6.3
6
*
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
27.2
6.3
8
*
N06AA09
ATC
amitriptyline; systemic
2.8
6.1
37
140
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
8.8
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
129
60
31.44
181.66
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
125
58
31.07
175.94
1.2
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
89
22
51.93
150.86
1.0
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
90
29
39.90
142.04
1.0
1.1
mg/l
212.4
228.3
0.25
75
23
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
90
30
38.56
140.58
1.1
1.2
mg/l
54.5
31.7
3.97
71
24
(3001604) Monocytes [#/volume] in Blood
388
1611
80.35
127.70
13.3
5.9
e9/l
0.5
0.5
0.92
374
1432
(3006315) Basophils [#/volume] in Blood
388
1615
80.01
127.33
13.3
5.9
e9/l
0.0
0.0
5.60
373
1433
(3019198) Lymphocytes [#/volume] in Blood
388
1670
75.56
122.34
13.3
5.9
e9/l
1.7
1.9
7.39
375
1508
(42870588) Differential panel, method unspecified - Blood
325
993
13.83
121.35
10.7
6.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
388
1682
74.63
121.27
13.4
6.4
e9/l
0.2
0.2
3.75
374
1522
(3005719) IgG [Mass/volume] in Serum or Plasma
169
247
11.21
120.75
3.1
2.7
g/l
9.6
10.4
2.18
155
231
(4027681)
76
26
35.96
117.16
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
386
1862
48.01
102.76
13.4
8.9
e9/l
3.2
4.0
20.96
371
1635
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
110
112
13.23
100.93
2.1
1.7
iu/ml
0.0
0.0
—
6
14
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
74
36
25.06
100.24
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
73
36
24.65
98.29
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
90
70
16.36
97.21
1.1
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
71
38
22.56
92.18
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
61
23
31.18
90.54
1.0
1.1
u/l
1.0
1.2
—
19
9
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
55
18
35.34
85.26
1.2
1.1
miu/ml
1614.6
1789.1
0.29
55
18
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
86
77
14.00
85.06
1.1
1.3
e6/l
149.5
9.8
0.50
72
60
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
86
77
14.00
85.06
1.1
1.4
e6/l
62.8
195.8
0.62
73
63
(3011412) CD3 cells [#/volume] in Blood
59
31
22.20
76.85
2.8
2.5
e9/l
1.0
1.5
1.04
28
16
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
78
78
12.21
71.39
1.0
1.3
mmol/l
3.5
3.5
0.30
73
73
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
48
23
23.62
64.71
2.4
2.4
%
13.9
12.8
0.15
20
13
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
60
46
15.20
64.50
1.3
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
39
10
43.16
64.19
1.0
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
107
198
7.04
58.80
3.2
1.6
g/l
0.9
1.3
2.05
107
187
(3010503) CD19 cells [#/volume] in Blood
39
17
25.34
54.35
2.8
2.1
e9/l
0.2
0.2
0.06
39
17
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
42
29
16.09
47.47
2.9
2.1
e6/l
994.3
864.6
0.40
28
11
(3023410) Appearance of Cerebral spinal fluid
48
44
12.28
45.95
1.2
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
49
5
111.57
45.94
1.2
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
43
33
14.50
45.83
1.1
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
288
1426
4.76
45.15
12.5
7.5
e9/l
0.0
0.0
0.07
268
1162
(3002582) Erythrocytes [#/volume] in Urine
197
755
4.21
43.98
3.7
2.5
e6/l
10.3
59.9
1.63
170
568
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
266
1259
4.41
43.97
2.5
2.3
nmol/l
98.5
73.5
19.18
260
1194
(3030467) Casts [#/volume] in Urine by Automated count
184
673
4.25
43.83
3.8
2.4
e6/l
0.1
0.3
1.39
156
489
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
217
896
4.16
43.45
4.6
2.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
29
11
28.37
42.22
2.8
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
96
218
5.50
41.67
4.6
4.2
%
0.0
0.1
1.24
14
52
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
34
20
18.51
41.51
2.6
2.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
94
213
5.48
40.85
4.6
4.2
%
0.0
0.2
0.70
13
47
(3002179) Metamyelocytes/100 leukocytes in Blood
94
216
5.40
40.17
4.5
3.9
%
0.1
0.8
1.77
13
42
(3000850) Epithelial cells [#/volume] in Urine
152
516
4.16
39.52
2.7
2.1
e6/l
6.0
8.7
0.72
143
450
(3017181) Myelocytes/100 leukocytes in Blood
97
233
5.19
39.33
4.5
4.1
%
0.0
1.0
3.86
14
59
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
103
267
4.87
38.03
2.5
2.2
au/ml
36.4
17.3
—
6
18
(36304419) Bacteria [Presence] in Urine
174
694
3.69
35.04
3.8
2.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
113
335
4.32
34.88
1.2
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
210
962
3.53
33.73
4.8
3.0
e6/l
25.4
39.7
0.55
175
637
(3031040) Bacteria [#/volume] in Urine by Automated count
310
1891
3.97
30.12
6.9
3.5
—
580.2
—
0
26
(40758558) Short blood count panel - Blood
173
774
3.20
27.63
8.0
6.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
111
379
3.68
27.43
3.6
2.2
e6/l
0.9
1.0
0.12
68
193
(3000060) B lymphocytes [#/volume] in Blood
23
14
17.38
27.37
2.2
2.0
e6/l
20.0
231.4
—
11
7
(3037467) Urinalysis macro (dipstick) panel - Urine
313
2110
3.33
21.95
6.5
3.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
28
9
33.34
21.79
2.3
1.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
28
9
33.34
21.79
2.3
1.8
%
7.1
5.6
—
28
9
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
100
369
3.29
21.39
3.5
2.3
e6/l
6.5
3.2
1.47
57
184
(3030905) Polymorphonuclear cells [#/volume] in Blood
39
71
5.99
20.99
4.2
4.0
e9/l
3.1
4.4
3.94
39
71
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
39
71
5.99
20.99
4.2
4.3
%
55.0
58.0
0.67
39
71
(3026008) Bacteria identified in Urine by Culture
144
670
2.81
20.26
4.3
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
170
871
2.67
19.67
10.5
4.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
23
25
9.71
19.27
2.7
3.2
%
47.4
47.5
—
9
6
(3017143) Hepatitis C virus Ab [Presence] in Serum
120
544
2.73
17.38
1.4
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
81
4.94
16.23
1.2
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
230
1468
2.36
15.35
3.3
5.5
umol/l
9.2
10.3
1.70
225
1399
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
145
768
2.40
14.79
1.5
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
233
1515
2.31
14.62
5.4
2.8
estimate
0.0
0.0
0.00
55
292
(3021601) Nitrite [Presence] in Urine by Test strip
233
1518
2.30
14.51
7.6
3.9
estimate
0.0
0.0
0.50
57
300
(3009261) Glucose [Presence] in Urine by Test strip
233
1532
2.27
14.01
5.4
2.8
estimate
0.0
0.0
0.80
57
287
(3024561) Albumin [Mass/volume] in Serum or Plasma
179
1089
2.18
12.67
3.5
4.3
g/l
39.0
37.4
5.89
171
1024
(3015736) pH of Urine
190
1189
2.15
12.45
4.6
2.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
61
239
2.84
11.33
2.7
2.2
u/l
59.0
1742.5
3.16
16
101
(3007164) IgA [Mass/volume] in Serum or Plasma
136
770
2.17
11.29
2.3
1.4
g/l
1.9
2.2
3.14
111
521
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
14
9.57
10.82
1.3
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
227
1575
2.04
10.72
2.4
3.9
mmol/l
5.8
6.4
7.18
215
1450
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
649
2.14
10.07
5.1
2.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
379
3333
4.38
9.08
10.0
10.1
mg/l
16.6
19.3
1.01
284
2511
(46235355) HIV 1 and 2 tests - Meaningful Use set
153
973
1.93
8.81
1.6
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
40
143
3.00
8.72
1.3
2.3
g/l
68.9
68.4
0.24
40
135
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
39
141
2.96
8.34
1.3
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
121
735
1.93
7.83
2.8
3.1
%
103.1
98.2
1.88
121
712
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
357
3087
2.63
7.80
9.1
8.2
ml/min/173m2
96.9
93.1
4.01
311
2521
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
6
18.80
7.64
2.6
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
343
2928
2.30
7.47
18.8
12.1
%
13.2
13.4
4.83
343
2873
(3041096) Erythrocytes [Presence] in Urine by Automated
140
924
1.80
6.82
4.5
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
43
186
2.47
6.52
2.5
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
170
1199
1.73
6.51
6.1
2.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
395
3792
+∞
6.49
24.4
15.0
e9/l
260.4
263.1
0.42
395
3737
(3004588) Protein electrophoresis panel - Serum or Plasma
31
115
2.84
6.34
1.1
2.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
395
3796
+∞
6.30
24.3
14.9
fl
90.8
90.1
3.87
395
3767
(3035941) MCH [Entitic mass]
395
3796
+∞
6.30
24.3
14.9
pg
30.1
30.1
0.27
395
3766
(3000963) Hemoglobin [Mass/volume] in Blood
395
3799
+∞
6.11
24.5
15.0
g/l
137.4
137.2
0.10
395
3770
(3010813) Leukocytes [#/volume] in Blood
395
3798
+∞
6.10
24.5
15.0
e9/l
5.9
6.6
11.58
395
3737
(3026361) Erythrocytes [#/volume] in Blood
395
3797
+∞
6.08
24.4
15.0
e12/l
4.6
4.6
0.05
395
3738
(3023103) Potassium [Moles/volume] in Serum or Plasma
361
3213
2.44
6.05
8.9
9.6
mmol/l
3.9
3.9
1.70
354
3125
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
281
2306
1.76
5.96
4.7
6.7
u/l
73.9
73.5
0.06
264
2182
(3037522) Nuclear Ab [Titer] in Serum
88
536
1.83
5.44
1.3
1.4
titre
370.0
482.7
0.35
20
105
(3023511) Choriogonadotropin [Units/volume] in Urine
31
134
2.43
4.73
1.7
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
69
3.00
4.67
1.1
2.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
21
4.86
4.55
1.8
4.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
30
4.09
4.47
1.4
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
153
1139
1.56
4.28
3.0
3.2
u/l
28.2
30.9
0.59
148
1096
(3052851) Hemolysis interference index of Serum or Plasma
20
74
2.79
4.15
1.5
2.5
—
—
—
0
0
(3013512) EKG study
93
621
1.65
4.07
2.7
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
256
1.95
4.07
6.7
2.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
275
2346
1.57
4.03
2.8
3.8
mm/h
8.2
8.5
0.18
255
2229
(3017732) Neutrophils [#/volume] in Blood
43
243
1.86
3.35
1.6
2.4
e9/l
3.9
4.2
0.56
38
219
(1761482) Bacteria [#/volume] in Urine by Culture
13
43
3.09
3.28
7.2
2.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
7
8.68
3.27
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
7
8.68
3.27
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
301
3288
0.64
3.25
3.1
3.5
mmol/l
1.5
1.5
0.70
283
3151
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
335
3050
1.65
3.18
4.8
4.7
mu/l
1.6
2.1
0.77
322
2929
(3029937) Albumin [Presence] in Urine by Test strip
105
764
1.51
3.11
6.9
3.0
estimate
0.0
0.0
0.80
58
299
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
8
7.59
3.06
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
180
0.27
3.04
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
180
0.27
3.04
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
180
0.27
3.04
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
180
0.27
3.04
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
209
0.32
3.03
1.1
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
303
0.38
2.99
1.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
307
3319
0.66
2.78
3.5
3.7
mmol/l
3.0
3.0
0.51
291
3170
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
187
0.31
2.73
1.3
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
291
3174
0.68
2.69
2.9
3.2
mmol/l
1.2
1.3
0.49
273
3037
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
185
1.86
2.66
1.2
1.4
miu/ml
185.6
263.6
—
8
100
(40761535) Cells panel - Urine sediment
32
178
1.87
2.65
6.7
3.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
7
7.22
2.55
1.2
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
448
0.53
2.52
1.5
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
16
4.43
2.48
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
160
0.30
2.47
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
110
2.06
2.46
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
42
646
0.61
2.42
1.3
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
8
6.31
2.38
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
22
3.69
2.37
1.1
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
153
0.32
2.33
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
153
0.32
2.33
1.2
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
18
3.94
2.26
1.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
36
2.82
2.21
1.2
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
30
3.05
2.16
1.1
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
308
3296
0.70
2.14
3.2
3.5
mmol/l
4.9
4.9
0.46
293
3165
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
117
933
1.36
2.02
1.7
1.7
pmol/l
102.3
98.5
0.38
64
517
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
26
3.12
2.02
1.5
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
19
99
1.97
1.93
5.4
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
39
576
0.64
1.89
1.4
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
7
22
3.22
1.89
1.9
3.2
%
49.9
59.0
—
7
16
(3032080) INR in Blood by Coagulation assay
106
842
1.35
1.87
2.4
5.8
inr
1.0
1.1
0.83
33
286
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
17
3.57
1.84
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
87
2.00
1.82
2.1
2.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
18
3.37
1.75
1.5
1.3
%
12.9
10.9
—
6
18
(44813793)
7
24
2.95
1.73
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
82
1.99
1.72
2.1
1.9
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
47
0.00
1.71
0.0
6.7
—
105.8
—
0
40
(3039000) Anion gap in Blood
0
47
0.00
1.71
0.0
6.7
—
11.0
—
0
40
(1761868) Lipid panel - Serum or Plasma
129
1531
0.77
1.70
2.0
2.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
0
49
0.00
1.69
0.0
3.6
—
35.6
—
0
40
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
269
2909
0.76
1.68
3.4
3.8
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
6
19
3.19
1.66
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
288
2655
1.31
1.61
4.1
4.1
pmol/l
14.2
14.3
0.17
277
2528
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
70
2.04
1.61
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
345
0.59
1.60
1.1
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
9
184
0.48
1.55
4.1
8.3
%
97.7
96.4
—
9
175
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
262
2832
0.78
1.54
3.4
4.1
mmol/mol
35.6
37.8
6.09
251
2728
(3009871) Measles virus Ab [Titer] in Serum
5
15
3.36
1.53
2.2
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
364
0.61
1.52
1.7
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
11
215
0.50
1.50
3.6
7.4
mmol/l
1.0
1.0
—
6
162
(3018418) pH of Serum or Plasma
90
721
1.32
1.49
2.5
3.6
ph
7.4
7.4
1.39
13
125
(3004809) Band form neutrophils/100 leukocytes in Blood
9
37
2.47
1.49
1.8
2.6
%
0.4
1.6
—
9
31
(40761511) CBC panel - Blood by Automated count
369
3557
1.57
1.42
11.5
9.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
142
1219
1.26
1.36
5.1
5.8
mmol/l
1.2
1.2
2.09
119
1037
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
105
1.75
1.35
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
37
0.00
1.35
0.0
1.4
—
—
—
0
0
(4062490)
9
42
2.17
1.34
1.8
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
205
0.52
1.32
1.9
1.8
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
12
215
0.54
1.27
3.4
7.4
kpa
12.3
13.8
1.02
12
205
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
12
215
0.54
1.27
3.4
7.4
kpa
5.0
5.2
0.35
12
204
(3019150) Specific gravity of Urine by Refractometry
82
663
1.30
1.27
5.8
3.0
kg/l
1.0
1.0
—
10
73
(3023368) Bacteria identified in Blood by Culture
69
548
1.31
1.22
2.9
3.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
101
844
1.26
1.21
1.5
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
47
355
1.37
1.16
1.9
2.0
umol/l
5.9
7.0
0.24
39
307
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
20
2.52
1.15
1.0
1.8
mg/l
2.0
3.5
—
5
20
(3051611) Lipemic interference index of Serum or Plasma
5
20
2.52
1.15
1.0
2.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
193
0.56
1.10
1.3
1.9
mg/l
2.0
2.6
—
6
137
(3008898) HLA-B27 [Presence]
13
217
0.59
1.09
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
21
2.40
1.09
1.4
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
350
1.36
1.09
1.5
1.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
97
1.68
1.08
1.1
1.1
u/ml
3.5
1.4
—
5
34
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
39
516
0.73
1.08
1.6
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
43
327
1.35
1.03
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
123
1.57
1.01
1.2
2.7
—
—
—
0
0
(44790047)
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(44806118)
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(44790048)
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(44790049)
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
31
0.00
0.97
0.0
1.6
—
1.3
—
0
24
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
62
1.80
0.95
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
449
1.29
0.94
2.1
3.1
ng/l
565.0
394.7
0.14
25
247
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
36
271
1.36
0.93
3.5
3.2
%
28.6
31.0
0.78
30
207
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
123
1079
1.20
0.93
3.9
5.0
mmol/l
1.2
1.2
1.38
113
994
(3003694) ABO and Rh group [Type] in Blood
86
1004
0.82
0.90
1.4
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
104
0.47
0.90
6.0
9.3
—
—
—
0
0
(4035726)
14
216
0.64
0.88
1.0
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
12
192
0.61
0.88
2.8
4.0
ug/l
1.9
5.6
1.64
12
143
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
432
0.74
0.87
1.4
1.9
—
—
—
0
0
(1002224) Polysomnography panel
16
237
0.66
0.84
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
45
1.79
0.84
1.6
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
141
0.56
0.84
1.8
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
14
213
0.64
0.84
1.6
2.3
nmol/l
14.2
13.6
0.08
14
201
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
46
1.75
0.83
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
46
1.75
0.83
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
8
47
1.72
0.81
1.0
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
33
1.83
0.79
1.5
2.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
25
0.00
0.79
0.0
1.2
—
7205.1
—
0
18
(3045414) Leukocytes [Presence] in Urine
18
123
1.49
0.79
1.4
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
26
0.00
0.78
0.0
2.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
99
0.50
0.78
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
54
1.68
0.75
1.3
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
127
1409
0.85
0.74
3.3
3.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
229
1.34
0.73
1.9
2.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
109
0.54
0.73
1.5
5.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
16
229
0.69
0.73
1.1
1.1
—
167.1
—
0
7
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
25
2.01
0.73
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
303
3143
0.85
0.69
19.6
12.6
g/l
332.0
333.2
1.96
303
3126
(3028271) Lactate [Moles/volume] in Capillary blood
5
27
1.86
0.68
1.4
1.6
mmol/l
1.4
1.6
—
5
27
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
1.4
1.6
g/l
0.6
1.0
—
5
27
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
85
742
1.19
0.68
1.5
1.7
mg/l
0.4
0.7
5.00
58
548
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
86
1.53
0.67
1.0
1.0
u/ml
6.7
3.7
—
8
39
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
50
597
0.81
0.66
1.3
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
351
1.25
0.66
1.9
2.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
70
1.59
0.66
1.1
1.1
u/ml
1.5
2.4
—
5
23
(3000764) Benzodiazepines [Presence] in Urine
18
246
0.72
0.65
1.7
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
138
1.40
0.63
1.6
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
21
0.00
0.60
0.0
10.3
—
39.4
—
0
10
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
340
0.78
0.58
1.3
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
81
1.50
0.57
1.1
1.0
u/ml
0.4
2.6
—
6
16
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
100
898
1.15
0.57
2.4
2.6
ng/l
90.1
17.5
0.46
57
393
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
122
0.65
0.55
1.6
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
60
1.51
0.54
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
38
1.59
0.54
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
38
1.59
0.54
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
38
1.59
0.54
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
196
1.29
0.54
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
39
1.55
0.53
1.5
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
343
1.22
0.52
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
368
0.80
0.52
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
40
1.51
0.52
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
40
1.51
0.52
1.0
2.3
—
—
—
0
0
(3019225) pH of Specimen
27
216
1.27
0.51
6.2
4.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
17
127
1.35
0.50
1.3
1.7
g/l
0.2
0.2
0.24
17
122
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
127
1.35
0.50
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
223
0.75
0.50
1.6
2.1
u/ml
15.2
38.6
1.41
17
212
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
234
0.76
0.50
1.7
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
163
1.30
0.49
1.2
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
45
1.57
0.49
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
27
218
1.26
0.48
1.9
4.2
u/l
202.2
236.1
1.57
27
211
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
81
0.61
0.46
2.4
1.9
%
13.2
13.2
—
5
81
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
83
0.60
0.46
1.2
1.2
ug/l
4.6
2.9
—
5
75
(3023323) Follitropin [Units/volume] in Serum or Plasma
42
359
1.19
0.45
1.4
1.3
iu/l
35.0
27.4
0.57
36
311
(3009445) Proteinase 3 Ab [Units/volume] in Serum
16
121
1.34
0.45
1.1
1.6
—
7.5
—
0
8
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
99
905
1.13
0.44
1.9
2.4
u/l
48.2
56.0
2.45
92
849
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
298
3063
0.89
0.43
3.2
3.4
mmol/l
5.5
5.7
1.85
276
2896
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
17
131
1.31
0.43
1.2
1.6
g/l
1.1
1.2
0.52
17
124
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
94
0.63
0.42
2.5
2.0
%
89.0
96.8
—
6
88
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
96
1.37
0.42
4.4
3.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
282
0.80
0.42
3.5
5.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
25
204
1.24
0.42
12.5
12.5
inr
1.0
1.1
—
8
34
(3028300) Cannabinoids [Presence] in Urine
20
249
0.79
0.41
1.7
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
149
0.73
0.41
1.5
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.4
—
596.9
—
0
17
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
248
0.80
0.40
1.6
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
18
0.00
0.40
0.0
2.1
—
0.9
—
0
13
(3000492) Spirometry study
32
376
0.84
0.39
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
24.0
—
0
19
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
225
0.79
0.39
1.4
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
74
671
1.13
0.38
1.3
1.3
iu/ml
14.0
24.6
0.97
15
221
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
68
1.33
0.38
1.9
3.4
—
845.7
—
0
7
(3014007) Fractional oxyhemoglobin in Arterial blood
8
116
0.68
0.37
4.5
9.1
%
96.5
94.0
—
8
116
(3015377) Calcium [Moles/volume] in Serum or Plasma
97
896
1.11
0.36
2.1
3.0
mmol/l
2.3
2.4
0.16
88
826
(3027944) Amphetamines [Presence] in Urine
20
244
0.81
0.36
1.6
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
42
1.44
0.35
1.2
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
191
1.22
0.34
1.8
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
52
1.35
0.31
1.9
3.4
—
5348.0
—
0
5
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
28
240
1.18
0.31
1.2
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
7
99
0.70
0.31
4.7
8.8
mmol/l
24.9
24.0
—
7
94
(3003327) Ova and parasites identified in Stool by Light microscopy
16
130
1.24
0.29
1.3
1.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
76
1.32
0.28
1.1
1.3
—
1.2
—
0
5
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
71
766
0.91
0.27
1.4
1.6
mmol/l
1.6
1.5
0.53
64
683
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
67
1.20
0.26
2.1
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
36
403
0.88
0.26
1.4
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
311
1.14
0.26
2.0
2.8
%
20.2
23.1
0.37
13
88
(36660697) Celiac disease serology panel - Serum
28
318
0.87
0.25
1.2
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
13
105
1.25
0.25
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
78
1.29
0.24
2.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
232
0.85
0.23
1.6
2.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
16
134
1.20
0.23
4.4
3.1
kpa
5.1
5.1
0.00
16
126
(3044640) Blood type and Crossmatch panel - Blood
84
892
0.93
0.23
1.9
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
39
1.29
0.23
1.8
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
93
0.75
0.22
1.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
135
0.81
0.22
1.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
196.4
—
0
11
(3043410) Blood group antigens tested for on Red Blood Cells
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(4133840)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.5
—
34.0
—
0
11
(40768806) Pleura Pathology biopsy report
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.6
—
7.7
—
0
10
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3004451) EKG impression Narrative
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
102
0.78
0.21
1.8
2.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
103
0.77
0.21
2.8
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
12
0.00
0.21
0.0
3.0
—
131.3
—
0
12
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
9.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
68
724
0.93
0.20
3.4
3.0
mmol/l
8.9
8.3
0.47
61
638
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
661
0.93
0.19
1.2
1.3
u/ml
2.6
11.1
2.02
23
302
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
243
1.12
0.17
1.2
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
234
1.12
0.17
1.8
1.9
ug/l
0.6
0.6
0.24
19
103
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
68
0.73
0.17
1.4
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
90
940
0.94
0.16
1.7
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
54
574
0.93
0.16
3.3
3.2
mg/l
74.2
421.5
0.99
28
374
(3020891) Body temperature
6
77
0.78
0.15
3.0
4.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
10
83
1.21
0.15
1.5
1.0
u/ml
1.1
1.3
—
5
42
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
76
724
1.06
0.15
1.5
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
192
0.88
0.15
1.7
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
159
0.88
0.13
4.3
7.2
—
—
—
0
0
(4034850)
9
108
0.83
0.13
7.8
7.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
12
104
1.16
0.12
1.1
1.3
—
3.3
—
0
10
(3012544) pH of Venous blood
19
172
1.11
0.11
2.1
3.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
86
1.17
0.11
1.2
2.5
mg/l
8.0
10.4
—
10
80
(3022621) pH of Urine by Test strip
18
164
1.10
0.10
2.7
2.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
114
0.87
0.09
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
114
0.87
0.09
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
56
1.07
0.08
1.2
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
56
1.07
0.08
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
57
592
0.96
0.08
3.9
3.9
mg/mmol
7.6
10.5
0.25
32
376
(3048689) Calprotectin [Mass/mass] in Stool
52
500
1.05
0.08
1.7
2.5
ug/g
71.7
113.1
1.06
37
400
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
70
0.85
0.07
1.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
225
1.07
0.07
1.2
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
75
1.07
0.07
1.4
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
76
1.05
0.07
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
77
1.04
0.07
1.8
1.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
78
1.03
0.07
1.9
1.9
pmol/l
208.0
232.7
—
8
73
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
78
1.03
0.07
1.0
1.1
—
14.7
—
0
7
(3028707) Methadone [Presence] in Urine by Screen method
9
104
0.86
0.06
2.3
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
334
3322
1.04
0.06
15.8
10.8
%
41.0
40.8
0.37
268
2866
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
67
653
1.03
0.05
1.5
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
109
0.92
0.04
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
132
1335
0.98
0.03
2.0
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
208
2065
1.02
0.03
2.6
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
87
883
0.98
0.03
1.3
1.3
u/ml
0.5
1.9
1.53
17
260
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
67
660
1.02
0.02
2.0
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
63
639
0.98
0.02
2.0
2.1
mg/l
2.6
2.8
0.34
55
557
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
107
0.93
0.02
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
167
0.96
0.01
1.9
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
164
1649
0.99
0.01
2.5
2.8
ug/l
96.8
88.7
0.35
155
1580
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
106
0.94
0.01
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
236
0.97
0.00
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
39
396
0.98
0.00
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
41
411
1.00
0.00
2.0
3.0
ng/l
483.8
636.5
0.23
29
339
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
123
0.97
0.00
1.1
1.3
—
—
—
0
0
(4010399)
18
177
1.02
0.00
1.4
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
35
355
0.98
0.00
1.3
1.2
iu/ml
215.5
158.2
0.35
14
156
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
214
0.98
0.00
1.8
2.1
ml/min/173m2
80.3
79.0
0.05
12
84
(3012095) Magnesium [Moles/volume] in Serum or Plasma
40
396
1.01
0.00
2.0
2.8
mmol/l
0.9
0.8
1.03
40
376
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
5.8
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
57
0.88
0.00
1.0
1.6
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
1.2
—
0
6
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
88
0.91
0.00
1.6
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
4.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
12.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
4.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
37.1
—
0
8
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
120
1.00
0.00
4.5
5.7
mmol/l
25.5
24.6
0.64
12
120
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
9
90
1.00
0.00
1.9
2.6
mmol/l
24.9
23.9
—
9
82
(3027315) Oxygen [Partial pressure] in Blood
5
49
1.02
0.00
2.8
2.0
kpa
9.2
9.3
—
5
49
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
15.2
—
0
6
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
56
0.89
0.00
1.6
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
130
1.00
0.00
1.7
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
16.2
—
0
7
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
1.8
—
0
9
(3045788) Cell count panel - Pleural fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.3
—
1.2
—
0
9
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
104.3
—
0
8
(3013290) Carbon dioxide [Partial pressure] in Blood
5
49
1.02
0.00
2.8
2.0
kpa
4.7
5.0
—
5
49
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
11.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MSMED_TERIFLUNOMIDE – Use of teriflunomide
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).